ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 124 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $125,000 | -41.3% | 57,768 | -5.0% | 0.06% | -37.5% |
| Q2 2021 | $213,000 | +0.9% | 60,785 | +183.5% | 0.09% | -1.1% |
| Q1 2021 | $211,000 | -7.5% | 21,443 | +1.8% | 0.09% | -6.3% |
| Q4 2020 | $228,000 | +53.0% | 21,057 | +45.7% | 0.10% | +21.8% |
| Q3 2020 | $149,000 | -56.6% | 14,457 | -12.0% | 0.08% | -51.9% |
| Q2 2020 | $343,000 | +3.0% | 16,434 | -51.8% | 0.16% | +18.2% |
| Q1 2020 | $333,000 | -26.0% | 34,113 | -12.7% | 0.14% | +85.1% |
| Q4 2019 | $450,000 | +254.3% | 39,082 | +67.4% | 0.07% | +184.6% |
| Q3 2019 | $127,000 | -56.7% | 23,351 | -5.3% | 0.03% | -58.1% |
| Q2 2019 | $293,000 | -41.6% | 24,652 | -70.3% | 0.06% | +19.2% |
| Q3 2018 | $502,000 | -34.2% | 82,998 | -42.3% | 0.05% | -92.3% |
| Q2 2018 | $763,000 | – | 143,951 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |